AGEN vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

AGEN

54.5
AI Score
VS
AGEN Wins

JBIO

32.8
AI Score

Investment Advisor Scores

AGEN

55score
Recommendation
HOLD

JBIO

33score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AGEN JBIO Winner
Net Income -3.08M -96.13M AGEN
Operating Income -20.17M -102.36M AGEN
ROE 1.1% -21.9% AGEN
ROA -1.4% -20.4% AGEN
Total Assets 226.80M 472.11M JBIO
Cash 3.00M 107.25M JBIO
Current Ratio 0.41 14.93 JBIO
Free Cash Flow -77.20M -67.93M JBIO

Relative Price Performance (Last 90 Days)

AGEN 1M: +0.7% · 3M: -5.9% JBIO 1M: +17.3% · 3M: -31.2%

Current Technical Phase

AGEN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.4 · Price: $6.73

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.0 · Price: $16.14

Fundamentals Snapshot

Metric AGEN JBIO
Market Cap — —
Forward P/E -42.1 -6.1
Trailing P/E 29.9 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 1.2% —
Operating Margin 0.4% 0.0%
EPS 0.23 -1.92
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AGEN is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.